Drug intelligence / Profile preview

Livomyn

Development stage
Unknown
Lead developer
Charak
Administration
Oral
01

Overview

Livomyn is a proprietary Ayurvedic hepatoprotective formulation developed by Charak Pharma. It is composed of a blend of time-tested, well-documented herbs, including Kalmegh (*Andrographis paniculata*), Bhumyamalaki (*Phyllanthus niruri*), Katuki (*Picrorhiza kurroa*), Punarnava (*Boerhavia diffusa*), Guduchi (*Tinospora cordifolia*), and Daruharidra (*Berberis aristata*). Livomyn is designed to support liver health, protect hepatocytes from toxin-induced damage, regulate bile flow, and maintain healthy liver enzyme levels (such as SGPT and SGOT). It is indicated for minor liver ailments, viral hepatitis, drug-induced hepatotoxicity, alcohol-induced hepatotoxicity, and cholestatic jaundice. Additionally, a variant called Livomyn-FL combines silymarin, resveratrol, N-acetylcysteine, and Kalmegh to support metabolic liver function related to non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

Brand names
LivomynLivomyn DropsLivomyn SyrupLivomyn TabletLivomyn-FL Tablet

Beyond the preview

Go deeper on Livomyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Livomyn.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call